"At Acuity Pharmaceuticals we faced many challenges back in 2003. Five years later, we can view our scientific and financial successes with the benefit of hindsight to seek the contributing factors to that success. BioAdvance was one of the first companies we presented our company to. We received quick feedback and then were involved in a thorough diligence process which gave us more input and encouragement. At that early juncture, BioAdvance decided to invest, yet it was far more than money that made the difference. The BioAdvance team provided contacts and an effective sounding board for our development during those formative years."
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
Dale Pfost
Former CEO
Acuity Pharmaceuticals
Philadelphia, PA
BioAdvance and Portfolio News Coverage
| 2010 | | | 2009 | | | 2008 | | | 2007 | | | 2006 | | | 2005 | | | 2004 | | | 2003 | | | 2002 | | | 2001 |
2004
|
November 19, 2004 - Yahoo Finance
BioAdvance Names Dr. Michael Pellini as First Entrepreneur-in-Residence |
| > View Article |
|
November 11, 2004 - RNAiNews
In Landmark Step, Acuity is First Firm to Begin RNAi-based Drug Study in Humans |
| > View Article |
|
November 11, 2004 - FDA News.com
Acuity Pharmaceuticals and Avecia Biotechnology Sign First-Ever manufacturing Agreement for Pharmaceutical Sirna |
| > View Article |
|
November 10, 2004 - BioWorld
Acuity Pharmaceuticals Inc., of Philadelphia |
| > View Article |
|
November 6, 2004 - DowJones Venture Wire
PA Early Stage Partners Closes $86M in Third Fund for Regional Investments |
| > View Article |
|
November 5, 2004 - Philadelphia Business Journal
Yaupon Therapeutics of Radnor PA initiated human clinical trials of its potential treatment for methamphetamine addiction. |
| > View Article |
|
November 1, 2004 - Philadelphia Business Journal
Alliance gets $3.7M to fund local bioinformatics |
| > View Article |
|
November 1, 2004 - Pennsylvania BioWatch
BioAdvance Sponsors Bioinformatics Alliance Retreat Highlighting Critical Role of Bioinformatics in 21st Century Drug Research |
| > View Article |
|
November 1, 2004 - Pennsylvania BioWatch
BioAdvance Company Acuity Pharmaceuticals Closes $15 Million Financing and Initiates First-ever Clinical Trials of an RNAI Therapeutics |
| > View Article |
|
November 1, 2004 - Philadelphia Inquirer
Third Quarter Venture Capital Investments |
| > View Article |
|
November 1, 2004 - BioWorld
Yaupon Therapeutics of Philadelphia, PA initiated a Phase 1 trial for lobeline |
| > View Article |
|
October 31, 2004 - Technology Times
BioAdvance Sponsors Life Sciences Achievement Awards |
| > View Article |
|
October 27, 2004 - DowJones Venture Wire Lifescience
Yaupon Raising $8M for Series A, First Addiction Product Enters Clinic |
| > View Article |
|
October 27, 2004 - Bitotech Week
Early stage life sciences fund raises $26M |
| > View Article |
|
October 20, 2004 - Bitotech Week
Early stage life sciences fund raises $26M |
| > View Article |
|
October 18, 2004 - Philadelphia Business Journal
Penn sees creation of area similar to Cambridge, Mass. |
| > View Article |
|
October 1, 2004 - Biotechnology Healthcare
A Business Model for a New Generation of Diagnostic Companies By Dr. Gary Kurtzman, BioAdvance |
| > View Article > View Article |
|
September 30, 2004 - Pennsylvania BioWatch
Innovation Zone Created in Philadelphia ’s University City |
| > View Article |
|
September 30, 2004 - Pennsylvania BioWatch
BioAdvance Ventures Announces Closing of $26M Early Stage Life Sciences Fund. |
| > View Article |
|
September 30, 2004 - Pennsylvania BioWatch
BioAdvance Greenhouse Fund Cycle 3 Applications Close |
| > View Article |
|
September 24, 2004 - Philadelphia Business Journal
BioAdvance, Quaker close on funding |
| > View Article |
|
September 24, 2004 - Philadelphia Inquirer
New fund to invest in Pennsylvania life sciences firms |
| > View Article |
|
September 24, 2004 - DowJones Venture Wire
BioAdvance Ventures Launches with $26M for Early Stage PA Deals |
| > View Article |
|
September 24, 2004 - Bio IT World
BioAdvance And Quaker Announce $26M Fund… |
| > View Article |
|
September 24, 2004 - BioCentury
BioAdvance Closes $26M Fund |
| > View Article |
|
September 14, 2004 - The New York Times
Method to Turn Off Bad Genes Is Set for Tests on Human Eyes (Acuity) |
| > View Article |
|
September 1, 2004 - Radiology
Contrast-enhanced MR Imaging of the Heart: Overview of the Literature (Eagle Vision) |
| > View Article |
|
February 13, 2004 - Philadelphia Business Journal
BioAdvance lists funding recipients |
| > View Article |
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.